Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report released on Monday. The firm issued a hold rating on the stock.

Retractable Technologies Price Performance

RVP opened at $1.09 on Monday. The stock has a fifty day simple moving average of $1.09 and a two-hundred day simple moving average of $1.15. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01. The company has a market cap of $32.63 million, a price-to-earnings ratio of -4.19 and a beta of 2.08. Retractable Technologies has a 12-month low of $0.87 and a 12-month high of $1.34.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%. The business had revenue of $7.60 million during the quarter.

Insider Transactions at Retractable Technologies

In related news, CEO Thomas J. Shaw bought 48,635 shares of the business’s stock in a transaction dated Thursday, May 16th. The shares were purchased at an average cost of $1.03 per share, with a total value of $50,094.05. Following the completion of the purchase, the chief executive officer now owns 14,417,148 shares in the company, valued at approximately $14,849,662.44. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Over the last three months, insiders have purchased 150,816 shares of company stock valued at $156,305. Insiders own 55.00% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.